AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
The current AstraZeneca(AZN) stock price is $167.00, with a market capitalization of 255.54B. The stock trades at a price-to-earnings (P/E) ratio of 24.55 and offers a dividend yield of 1.68%.
As of 2026-10-20, AstraZeneca(AZN) stock has fluctuated between $166.84 and $167.00. The current price stands at $167.00, placing the stock +0.1% above today's low and 0.0% off the high.
The AstraZeneca(AZN)'s current trading volume is 5.44K, compared to an average daily volume of 2.96M.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $153.41.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $153.41.
AZN News
Oracle Corp. (NYSE:ORCL) announced Tuesday a nonbinding agreement with AstraZeneca Plc (NYSE:AZN) to explore using artificial intelligence and real-world data t...
Oracle (ORCL) announced an agreement with AstraZeneca (AZN) to explore how AI and real-world data can help clinicians identify eligible patients for clinical tr...
The first program under the collaboration will focus on hypertension care and clinical research in Abu Dhabi. Paul Ellis / Agence France-Presse / Getty Images...
Analyst ratings
91%
of 11 ratingsMore AZN News
An update from Innate Pharma SA ( (FR:IPH) ) is now available. Innate Pharma SA, a Marseille-based clinical-stage biotech specializing in cancer immunotherapie...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. AstraZeneca plc (AZN) is advancing a late-stage study in ovarian and related canc...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The BRISOTE trial is a Phase 3b study run by AstraZeneca to test benralizumab as an ad...
...
In the latest trading session, Astrazeneca (AZN Quick QuoteAZN - Free Report) closed at $166.68, marking a +2.87% move from the previous day. This move ou...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The Phase I study titled “A Study to Assess the Relative Bioavailability of Different...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. AstraZeneca’s latest update on trial NCT03423628 marks a key step in its push into bra...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.